Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SOBR Safe Announces Initial SOBRcheck Purchase By Butterfield Onsite Drug Testing

SOBR Safe Announces Initial SOBRcheck Purchase By Butterfield Onsite Drug Testing

Prominent Third-Party Administrator Launches SOBRsafe Solutions to Its Established Customer Network

byBenzinga Newsdesk

August 18, 2022

1 minute read

Prominent Third-Party Administrator Launches SOBRsafe Solutions to Its Established Customer Network

$100 Invested In NXP Semiconductors 10 Years Ago Would Be Worth This Much Today

By Benzinga Insights

October 31, 11:30 AM

NXP Semiconductors (NASDAQ:NXPI) has outperformed the market over the past 10 years by 6.09% on an annualized basis…

NXPI

EXCLUSIVE: Grove’s Upexi Scoops LuckyTail Pet Care Company For Undisclosed Terms

By Anusuya Lahiri

August 16, 8:00 AM

Grove, Inc's (NASDAQ: GRVI) Upexi unit finalized the acquisition of the international pet care brand, LuckyTail, Inc.

AMZN

Ladenburg Thalmann Initiates Coverage On Capricor Therapeutics with Buy Rating, Announces Price Target of $15

By Benzinga Newsdesk

October 26, 8:32 AM

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Capricor Therapeutics (NASDAQ:CAPR) with a Buy rating and announces Price Target of $15.

CAPR

Why Tandem Diabetes Care Shares Are Falling Today

By Vandana Singh

May 4, 10:03 AM

Tandem Diabetes Care Inc (NASDAQ: TNDM) shares are down Thursday morning as its Q1 results missed Street expectations.

TNDM

SOBR Safe Announces Initial SOBRcheck Purchase By Butterfield Onsite Drug Testing

Related Posts

$100 Invested In NXP Semiconductors 10 Years Ago Would Be Worth This Much Today

EXCLUSIVE: Grove’s Upexi Scoops LuckyTail Pet Care Company For Undisclosed Terms

Ladenburg Thalmann Initiates Coverage On Capricor Therapeutics with Buy Rating, Announces Price Target of $15

Why Tandem Diabetes Care Shares Are Falling Today